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doi:10.1016/j.ejvs.2010.06.009Abstract Objectives: We investigated the incidence of thrombo-embolectomy in upper-limb
and prognosis with respect to arm amputation, stroke and death.
Methods: We performed a national cohort study of individuals, aged 40e99 years, and under-
going first-time thrombo-embolectomy in the brachial, ulnar or radial artery in Denmark from
1990 to 2002. The data were retrieved from the National Vascular Registry and from the
National Registry of Patients and the Civil Registration System. Patients were followed until
2006 to ascertain the occurrence of amputation and stroke and until 2007 with respect
to death.
Results: In total, 1377 incident cases of thrombo-embolectomy were registered, comprising
504 (36.6%) males with a mean age of 72.0 (standard deviation (SD) 12.4) years and 873
(63.4%) females with a mean age of 77.2 (SD 11.7) years. Incidence was 3.3 (95% confidence
interval (CI): 3.1e3.7) for males and 5.2 (95% CI: 4.9e5.6) for females per 100000 person-
years. After thrombo-embolectomy, upper-limb amputation was performed in 11 (incidence
2.2%; 95% CI: 1.2e3.4) males and 31 (3.6%; 95% CI: 2.5e4.9) females. Age- and sex-specific risk
of stroke was 2e16 times higher, and risk of death 3e11 times higher, than in the general
population.
Conclusions: Upper-limb thrombo-embolectomy is associated with an increased risk of limb
amputation, stroke and death.
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Upper-Limb Thrombo-Embolectomy 629Major embolism to the arm is associated with some or all
symptoms of sudden limb ischaemia: pulselessness, pain,
pallor, paraesthesiaandparalysis.1 Theestablished treatment
of the disease is acute thrombo-embolectomy, commonly by
the Fogarty technique: transverse brachial arteriotomy
through an S-shaped incision in fossa cubiti and removal of
thromboembolic material with a balloon catheter.1,2 The
procedure can be performed under local anaesthesia.
Despite prompt surgical intervention, reported rates of
brachial amputation range from 0% to 18% or more.3,4 Yet,
incidence of upper-limb embolism and prognosis after
thrombo-embolectomy are not known.
Data from administrative and quality-control databases
provide an opportunity to study rare diseases such as upper-
limb embolism and its treatment.5 They also provide an
opportunity to observe large cohorts over a long period of
time. By these means, we can present the first report of
population-based incidence rates of thrombo-embolectomy
from the brachial, ulnar or radial arteries and overall risk of
peri- and postoperative limb amputation, stroke and death.Methods
We retrieved data from the Danish National Vascular
Registry6 and from the Danish National Registry of Patients.7
We included patients, aged 40e99 years, in whom first-time
upper-limb thrombo-embolectomy was performed between
1 January 1990 and31December 2002.We identified subjects
by the surgical procedures, thrombo-embolectomy in
brachial and thrombo-embolectomy in ulnar or radial artery,
coded according to the Danish Classification of Surgical
Procedures (codes: 86 823 and 86 824) or the Nordic Classi-
fication of Surgical Procedures (codes PBE20 and PBE30). In
the Danish HealthCare System, written documentation of
any treatment of the patient is compulsory, and operation
codes are also compulsory linked to the operation. The
surgical procedure codes were analysed jointly, since
embolus can often be found in all three arteries at the same
time.1 Retrievable medical records were reviewed by clini-
cians experienced in cardiovascular medicine (LA and LF).
Review data were collected using a detailed standardised
form. Embolectomy in the brachial, ulnar or radial arterywas
considered confirmed when the reviewer verified a descrip-
tion of the surgical procedure in the medical record. Data
from the medical records were used to validate registries
prior to this study and have previously been published in
detail.8 In summary, we found high positive predictive value
of correct registration in the Danish National Vascular
Registry (97.5%). Theestimated number (captureerecapture
method) of procedures not registered in any of the registries
was low. The authors (LVA and LF) also reviewed medical
record information about atrial fibrillation, including elec-
trocardiograms, printout from telemetry, Holter recordings
or records of atrial fibrillation confirmed by a physician.
Summary data about the background population were
uploaded from Statistics Denmark.9
Outcomesof interestwereupper-limbamputation, stroke
and death. Excess stroke and mortality were calculated
relative to the background population. The outcomes were
measured at, or after the first thrombo-embolectomy. We
used the Danish Classification of Surgical Procedures or theNordic Classification of Surgical Procedures coding system
codes 81 000, 81 001, 81 010, 81 011, NBQ-09, -19, -99, NCQ-
09, -19, -99 to identify upper-limb amputation (any position
from shoulder towrist). For stroke,weused the International
Classification of Diseases, 8th Revision (ICD-8) or the Inter-
national Classification of Diseases, 10th Revision (ICD-10)
codes 432e434, 436, I63, I64. Vital and emigration status was
established by querying the Danish Civil Registration
System.10 Patients were followed until September 2006 to
ascertain the occurrence of amputation and stroke, and until
June 2007 to ascertain vital and emigration status.
Diagnoses, before or at the time of the first thrombo-
embolectomy, of myocardial infarction, hypertension, dia-
betes mellitus and atrial fibrillation were retrieved from
the Danish National Registry of Patients.
The HealthCare System in Denmark was, during the
study period, tax-financed, non-profit and free of charge
for all inhabitants.
The Danish National Vascular Registry was initiated in
1989.6,8 The purpose of the registry is primarily quality
monitoring of procedures, and information includes patients’
civil registration numbers, admission hospitals and depart-
ments, dates of admission and discharge and surgical proce-
dures using the Danish Classification of Surgical Procedures
(until 31 December 1995) or the Nordic Classification of
SurgicalProcedures (from1January 1996) coding system.The
operating surgeon assigned surgical procedure codes imme-
diately after the operation.
The Danish National Registry of Patients was established in
1977 and records 99.4% of all non-psychiatric hospital admis-
sions in Denmark.7,11 Since 1995, it has also included data on
outpatient and emergency clinic patients. Reporting to the
Danish National Registry of Patients is mandatory, and it
contains data on patients including civil registration number,
admission hospitals and departments, dates of admission and
discharge, surgical procedures performed using the Danish
Classification of Surgical Procedures or the Nordic Classifica-
tion of Surgical Procedures coding system and one or several
discharge diagnoses using the ICD-8 or the ICD-10. The dis-
charging physician assigned all discharge diagnoses.
All residents in Denmark are assigned a unique 10-digit
code, given to each individual having, or having had an
address in Denmark since April 1968.10 Data are stored in
the Danish Civil Registration System containing electronic
records of any change in vital and emigration status. We
used the unique civil registration number to link records.
The Danish National Board of Health and the Danish Data
Protection Agency approved the study.Statistical Analysis
Descriptive statistics are presented as percentages or
means and standard deviations. Confidence intervals (95%
CI) around the estimates were calculated. We computed
incidence rates of upper-limb thrombo-embolectomy by
dividing the number of incident cases by the underlying
follow-up time in person-years in the Danish population. It
was assumed that population size and distribution, by sex
and age, were unchanged over the period, and we used
population figures for 1996, which corresponds to the
middle of the study period. Patients with stroke prior to
Table 1 Characteristics of 1377 patients with thrombo-
embolectomy in Denmark.
Men Women
Number of subjects 504 (36.6%) 873 (63.4%)
Mean age 72 (SD 12.4) 77.2 (SD 11.7)
History and/or presence (%) of:
Myocardial infarction 19.4 12.3
Diabetes 9.7 8.5
Hypertension 15.7 18.1
Atrial fibrillation in NRP 31.0 36.0
Atrial fibrillation recorded in
medical recordsa 58.9 64.9
Smoking 47.0 28.3
NRP: Danish National Registry of Patients.
a According to validation study of the comprehensiveness of
registration of atrial fibrillation in patients with thrombo-
embolectomy.
630 L.V. Andersen et al.thrombo-embolectomy were excluded from analyses
specific for that endpoint.
Amputation and stroke incidence rates and mortality
after thrombo-embolectomy were computed by dividing the
number of incident cases by the corresponding follow-up
time in person-years among patients. We computed excess
stroke and excess mortality using the background population
as a reference.12 KaplaneMeier survival analysis was used to
estimate cumulative risk for upper-limb amputation, stroke
and death, separately in males and females.
Temporal trends of stroke and mortality were calculated
for early period (1990e1996) versus late period (1997e2002).
Weused theCoxproportional hazardsmodel andadjusted for
sex and age. The early period was used as reference.Table 2 Distribution of atrial fibrillation in Danish patients wit
Age
group
Registered in NRP (%)
Number of cases
with atrial
fibrillation
Number of cases
without atrial
fibrillation
Total number
of cases
Men
40e49 2 (6.9) 27 (93.1) 29
50e59 11 (17.7) 51 (82.3) 62
60e69 26 (27.7) 68 (72.3) 94
70e79 54 (34.6) 102 (65.4) 156
80e89 56 (40.0) 84 (60.0) 140
90e99 7 (30.4) 16 (69.6) 23
Total 156 (31.0) 348 (69.0) 504
Women
40e49 0 (0.0) 31 (100) 31
50e59 5 (10.0) 45 (90.0) 50
60e69 22 (20.8) 84 (79.2) 106
70e79 84 (33.9) 164 (66.1) 248
80e89 159 (46.0) 187 (54.0) 346
90e99 44 (47.8) 48 (52.2) 92
Total 314 (36.0) 559 (64.0) 873
NRP: Danish National Registry of Patents.Statistical analyses were performed using statistical
packages BMPD 8.1 (Statistical Solutions Ltd., Cork, Ireland)
and STATA 10, (Stata Corporation, College Station, TX, USA).
Results
Initially, we identified 1434 incident cases of upper-limb
thrombo-embolectomy. A total of 56 cases were excluded
based on age restriction (40e99 years), and one patient was
excluded due to data errors. In all, 1377 patients were
included in the study, comprising 504 (36.6%) males and 873
(63.4%) females. The number of patients undergoing upper-
limb thrombo-embolectomy was approximately constant
over the study period. The mean follow-up was 4.1 years
(range from 0 to 17.4 years).
We could retrieve 1018 medical records out of a total of
1377 identified cases. Most of the missing records were
more than 10 years old. The health authorities in Denmark
require medical record storage for at least 10 years, hence,
older records may have been destroyed owing to storage
problems. Otherwise, we could not discover any reason for
the missing records.
Thrombo-embolectomy was performed on the right arm
in 584 cases (57.6%), on the left arm in 432 cases (42.6%)
and in two cases on both arms at the same time.
Table 1 presents characteristics of the thrombo-embo-
lectomy patients.
Table 2 shows results of the validation study of the
diagnosis of atrial fibrillation among thrombo-embolectomy
patients. About a third of males (31.0%) and females
(36.0%) had a diagnosis of atrial fibrillation in the Danish
National Registry of Patients.
In our validation study of the comprehensiveness of
registration of atrial fibrillation in patients with thrombo-h upper-limb thrombo-embolectomy.
Medical records review (%)
Number of cases
with atrial
fibrillation
Number of cases
without atrial
fibrillation
Total number
with information
on cardiac status
1 (5.3) 18 (94.7) 19
11 (26.8) 30 (73.2) 41
35 (48.6) 37 (51.4) 72
79 (67.5) 38 (32.5) 117
78 (75.7) 25 (24.3) 103
15 (75) 5 (25) 20
219 (58.9) 153 (41.1) 372
0 (0.0) 16 (100) 16
4 (11.1) 32 (88.9) 36
32 (42.1) 44 (57.9) 76
118 (63.4) 68 (36.6) 186
222 (79.6) 57 (20.4) 279
56 (76.7) 17 (23.3) 73
432 (64.9) 234 (35.1) 666
Figure 1 Arm amputation after thrombo-embolectomy,
cumulative incidence in Denmark Patients aged 40e99 years at
1st operation (N Z 1377).
Upper-Limb Thrombo-Embolectomy 631embolectomy, we were able to retrieve 1176 (85.4%)
medical records out of 1377 patients registered with
thrombo-embolectomy. Of those, 138 did not contain any
information regarding cardiac status (13.3% of males and
10.8% of females), 387 had no atrial fibrillation and 651
patients had atrial fibrillation prior to or at the time of
hospitalisation for thrombo-embolectomy. Thus, in those
patients with information on cardiac status, we found that
58.9% of males and 64.9% of females had a diagnosis of
atrial fibrillation in their medical records.
In total, 19 cases of brachial ischaemia were caused by
trauma or medical intervention. There were eight acci-
dents, or other trauma to the arm, and there were two
cases after heart catheterisation using the radial approach,
three after angiography, four after puncturing the radial
artery for blood gas analysis, one after high-dose chemo-
therapy and one after inserting a haemodialysis needle into
an arteriovenous fistula.
The mean annual incidence rates of upper-limb thrombo-
embolectomy are presented in Table 3. A higher incidence
among females diminished after adjusting for age.
None of the patients had upper-limb amputation prior to
thrombo-embolectomy. After thrombo-embolectomy,
upper-limb amputation was performed in 11 (incidence
2.2%; 95% CI: 1.2e3.4) males and 31 (3.6%; 95% CI: 2.5e4.9)
females. The cumulative risk of amputation at 30 days was
2.0% (95% CI: 1.1e3.9) for males and 2.2% (95% CI: 1.3e3.5)
for females, 1- and 5-year risk were the same 2.5% (95% CI:
1.4e4.5) for males while for females 1-year risk was 3.9%
(95% CI: 2.7e5.6) and 5-year risk was 4.4% (95% CI: 3.1e6.4)
(Fig. 1). Females had persistent risk of amputation and
most amputations were performed within the first post-
operative year. Most amputations in males were performed
within the first 30 days, postoperatively. Females hadTable 3 Incidence of thrombo-embolectomy in Denmark
from 1990 to 2002.
Age
group
Number
of cases
Population
size (1996)a
Incidence per 100,000
person-years (95% CI)b
Men
All 504 116,0347 3.3 (3.1e3.7)
40e49 29 389,644 0.6 (0.4e0.8)
50e59 62 325,875 1.5 (1.1e1.9)
60e69 94 220,516 3.3 (2.7e4.0)
70e79 156 157,072 7.6 (6.5e8.9)
80e89 140 608,75 17.7 (14.9e20.9)
90e99 23 6365 27.8 (17.6e41.7)
Women
All 873 129,1395 5.2 (4.9e5.6)
40e49 31 378,297 0.6 (0.4e0.9)
50e59 50 322,731 1.2 (0.9e1.6)
60e69 106 242,100 3.4 (2.8e4.1)
70e79 248 211,193 9.0 (7.9e10.2)
80e89 346 117,242 22.7 (20.4e25.2)
90e99 92 198,32 35.7 (28.8e43.8)
a Study period was thirteen years: 1990e2002.
b CI: confidence interval; Background population in the middle
of the study period in 1996 counted in all 2,451,742 inhabitants
aged 40 till 99.a higher risk of amputation (hazard ratio (HR), 2.3; 95% CI
2.3e4.9; adjusted for age and co-morbidity: history of
myocardial infarction, hypertension or diabetes) compared
with men. Further, younger age was associated with risk of
amputation, HR by 1 year increment in age: 0.95 (95% CI:
0.92e0.97).
In all, 237 (19.1%) patients experienced a first stroke at
or after thrombo-embolectomy; of those, 20 had a stroke at
the index date. Table 4 shows the incidence rates and
excess risk of stroke stratified by age and sex. Incidence
rates increased by age and excess risk of stroke were
higher for females than for males in those above 70 years
(Table 4). The cumulative risk of stroke at 30 days was 4.7%
(95% CI: 3.0e7.3) for males and 6.0% (95% CI: 4.5e8.1) for
females. One-year risk was 10.6% (95% CI: 7.6e14.6) for
males and 14.8% (95% CI: 12.0e18.1) for females. Five-year
risk was 17.9% (95% CI: 13.6e23.7) for males and 31.9% (95%
CI: 27.0e37.7) for females (Fig. 2).
KaplaneMeier survival distribution is presented in Fig. 3.
For males, 30-day cumulative mortality rate was 14.1% (95%
CI: 11.3e17.4), 1-year rate was 33.7% (95% CI: 29.8e38.0)
and at 5 years was 63.1% (95% CI: 58.9e67.3). For females,
30-day cumulative mortality rate was 12.8% (95% CI:
15.5e20.6), 1-year rate was 38.5% (95% CI: 34.2e43.3) and
at 5 years was 66.3% (95% CI: 63.2e69.4). Table 5 shows
estimated mortality rates and excess mortality relative to
the background population. Overall relative risk (RR) of
death after thrombo-embolectomy was 4 times higher than
that of the background population. When stratified by age,
excess mortality was relatively highest among younger
patients (Table 5).
We have data on anti-thrombotic therapy for only 59.2%
of our cases. Anticoagulation with vitamin K antagonists
was prescribed to 29.8% of men and 30.5% of women after
the operation. However, we have no data on prescription of
vitamin K antagonists for the period after the discharge
and, therefore, our data on use of vitamin K antagonists are
insufficient to draw any conclusions.
Temporal trends of stroke and mortality were calculated
for early period (1990e1996) versus late period
(1997e2002). When adjusting for age and sex, HR for stroke
was 1.03 (95% CI: 0.79e1.33), and, for mortality, 0.86(95%
CI: 0.76e0.97) in favour of the late period.
Table 4 Stroke after upper-limb thrombo-embolectomy in Denmark.
Age
group
Persons
at risk
Person-years
at risk
Observed
cases
of stroke
Expected
cases
of stroke
Incidence rate per
1000 person-years
(95% CI)
Relative Riska
(95% CI)
Estimated
excess
casesa
Percentage
of excess
stroke
Men
All 454 1749 68 20.6 38.9 (30.2e49.3) 3.3 (2.6e4.2) 47.4 100
40e49 29 159 5 0.31 31.4 (10.2e73.4) 16.1 (5.2e37.6) 4.69 10
50e59 60 406 9 1.99 22.2 (10.1e42.1) 4.5 (2.1e8.6) 7.01 15
60e69 85 371 15 3.69 40.4 (22.6e66.7) 4.1 (2.3e6.7) 11.31 24
70e79 142 529 19 8.41 36.0 (21.6e56.1) 2.3 (1.4e3.5) 10.59 22
80e89 117 262 18 5.71 68.7 (40.7e108.6) 3.2 (1.9e4.9) 12.29 26
90e99 21 22 2 0.51 91.0 (11.0e328.4) 3.9 (0.04e14.2) 1.49 3
Women
All 790 2813 169 34.0 60.1 (51.4e69.9) 5.0 (4.3e5.8) 135.0 100
40e49 31 234 3 0.33 12.8 (2.6e37.5) 9.1 (1.8e26.6) 2.67 2
50e59 48 311 5 0.94 16.1(5.2e37.5) 5.3 (0.2e12.4) 4.06 3
60e69 100 535 17 3.52 31.8 (18.5e50.9) 4.8 (2.8e7.7) 13.48 10
70e79 223 794 56 10.70 70.5 (53.3e91.6) 5.2 (4.0e6.8) 45.30 34
80e89 308 815 72 16.12 88.3 (69.1e111.3) 4.5 (3.5e5.6) 55.88 41
90e99 80 125 16 2.36 128.0 (73.2e207.9) 6.8 (3.9e11.0) 13.64 10
a Compared to risk in the background population.
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Thrombo-embolectomy is considered as the treatment of
choice in patients, who present with ‘acute’ ischaemia of
the upper-limb due to embolism.1,13 In the Danish pop-
ulation aged 40e99 years, we found an overall incidence of
upper-limb thrombo-embolectomy of 3.3 among males and
5.2 among females per 100 000 person-years. A review from
1998 estimated the incidence of upper-limb ischaemia in an
unselected population to be 1.2e3.5 per 100,000 person-
years.14 The estimation was based on two studies, one
single-centre study from Finland responsible for acute
surgical treatment for a population of about 430,000 people
during 26 years and one study from Sweden in the great
Stockholm area, with a study population of approximately
1.5 million, during 1 year.15,16
Since only few patients underwent systematic heart-rate
monitoring for detection of atrial fibrillation, echocardiog-
raphy, angiography or examination for coagulationdisorders,Figure 2 Cumulative stroke incidence by sex after upper-
limb thrombo-embolectomy in Denmark Patients aged 40e99
years at 1st operation.detailed analysis of the aetiology of upper-limb embolism
cannot be given. Embolism from the heart has been consid-
ered the major cause of acute upper-limb ischaemia in
previous studies,1,4,13,14,17 an understanding supported by
the present study, because our validation study showed that
62.7% of patients had atrial fibrillation. The much lower
estimate of prevalence of atrial fibrillation provided by the
Danish National Registry of Patients (34.1%) suggests a high
degree of underreporting, and our data support the view that
atrial fibrillation is the most important single risk factor for
disease requiring upper-limb thrombo-embolectomy. A high
prevalence of atrial fibrillation among patients with acute
upper-limb ischaemia was also found by others.4,13
The incompleteness of reporting of atrial fibrillation to
the National Registry of Patients can be because many
patients were transferred from one department to another
(from medical to surgical to medical ward and vice versa)
leading to lack of responsibility in reporting of conditions of
co-morbidity, including atrial fibrillation. Another reasonFigure 3 Cumulative mortality rate by sex after upper-limb
thrombo-embolectomy in Denmark Patients aged 40e99 years
at 1st operation.
Table 5 Mortality after upper-limb thrombo-embolectomy in Denmark.
Age
group
Persons
at risk
Person-years
at risk
Observed
number
of deaths
Expected
number
of deaths
Mortality rate per
1000 person-years
(95% CI)
Relative
Riska
(95% CI)
Estimated
excess
deathsa
Percentage
of excess
deaths
Men
All 504 2124 389 96.6 183.1 (165.4e202.3) 4.0 (3.6e4.4) 292.4 100
40e49 29 191 9 0.91 47.1 (21.5e89.4) 9.9 (4.5e18.7) 8.09 3
50e59 62 489 27 5.95 55.2 (36.4e80.3) 4.5 (3.0e6.6) 21.05 7
60e69 94 446 66 13.2 148.0 (114.4e188.3) 5.0 (3.9e6.4) 52.8 18
70e79 156 639 130 35.5 203.4 (170.0e241.6) 3.7 (3.1e4.3) 94.5 32
80e89 140 329 135 34.8 410.3 (344.0e485.7) 3.9 (3.3e4.6) 100.2 34
90e99 23 32 22 6.2 687.5(430.9e1040.9) 3.5 (2.2e5.3) 15.8 5
Women
All 873 3468 706 174.7 203.6 (188.8e219.2) 4.0 (3.7e4.4) 531.3 100
40e49 31 264 10 0.91 37.9 (18.2e69.7) 10.9 (5.3e20.2) 9.09 2
50e59 50 342 23 2.71 67.3 (42.6e100.9) 8.5 (5.4e12.7) 20.29 4
60e69 106 664 63 13.2 94.9 (72.9e121.4) 4.8 (3.7e6.1) 49.8 9
70e79 248 1030 202 44.1 196.1 (170.0e225.1) 4.6 (4.0e5.3) 157.9 30
80e89 346 1001 319 87.0 318.7 (284.7e355.6) 3.7 (3.3e4.1) 232.0 44
90e99 92 168 89 26.8 529.8 (425.4e651.9) 3.3 (2.7e4.1) 62.2 12
a Compared to risk in the background population.
Upper-Limb Thrombo-Embolectomy 633for lack of recording of atrial fibrillation could be that our
mostly old patients may have so many conditions of co-
morbidity that it was not possible, within a reasonable
amount of time, to record all those conditions. Further-
more, the beginning of our study period (from 1990 to 2002)
coincides with the first reports on efficacy of warfarin on
risk of stroke in atrial fibrillation.18e20 Subsequently, more
awareness was placed on atrial fibrillation. This may, in
part, explain the underreporting of atrial fibrillation to the
National Registry of Patients.
Some authors report that atherosclerosis does not
develop in brachial arteries,21 whereas others report
thrombosis as a cause of upper-limb ischaemia in 5e35% of
cases.14 However, thrombosis of an upper-limb usually
requires bypass surgery, and thrombo-embolectomy is inap-
propriate.14 Due to awell-developed collateral vascular tree
of the upper-limb, it is believed that arterial stenosis with
thrombosis in situ rarely presents acutely. Nonetheless, we
cannot exclude thrombosis in situ in some of our patients.
The right arm was more often affected than the left one,
in our study. It could possibly be because the diameter of
the brachiocephalic artery is larger than that of the left
subclavian, and because of the favourable angle between
the brachiocephalic artery and the aorta, so that the
former receives a larger proportion of emboli from the
heart. The same observation was made by others.13
Among 1377 patients, 42 had upper-limb amputation.
We found a high incidence of stroke occurring concur-
rently with or following limb thrombo-embolectomy. The
incidence of stroke in males was 3 times higher, and in
females 5 times higher, than the incidence in the back-
ground population.
We observed mortality rates 4 times higher than those in
the background population, and the excess mortality was
most evident in the youngest patients. One-month
mortality rate was 14.5%. Deguara and colleagues reported
a 30-day mortality rate of 18.2%.4 For lower-limb thrombo-embolectomy, 30-day mortality rate was 22%. The aetiol-
ogies of disease requiring lower and upper-limb thrombo-
embolectomy differ. Acute upper extremity ischaemia is
most often caused by embolism, while acute lower-limb
ischaemia is more often caused by in situ thrombosis.22
Patients who underwent thrombo-embolectomy had an
increased risk of stroke and death compared with patients
of the same age in the general population (Tables 4 and 5).
This is most likely secondary to an increased prevalence of
co-morbid factors in patients undergoing thrombo-embo-
lectomy, rather than the operation itself. Upper-arm
embolism is therefore best regarded not as a cause of
death, but rather as a marker of overall poor prognosis.
Licht and colleagues found that causes of death in patients
with upper-limb thrombo-embolectomy were mainly
cardiovascular (22%) and cerebrovascular (13%).23
Females were affected more often than males, as has
been observed by others.2,13 More females (64.9%) than
males (58.9%) had atrial fibrillation before or at the time of
thrombo-embolectomy. The dissimilarity of stroke inci-
dence and excess rate of stroke between men and women
could be due to differences in anticoagulation treatment. A
Danish study showed that prescription of oral anticoagu-
lants to patients with atrial fibrillation in the period from
1991 to 1998 was less than optimal, and prescription of oral
anticoagulants to females lagged behind that of males.24
The strength of the present study is the use of nation-
wide, well-validated registries with long and complete
follow-up. The Danish National Vascular Registry was suit-
able for research purposes.8,25,26 The estimated number of
thrombo-embolectomy cases not registered in any of the
two registries was found to be very low.
The follow-up data were complete for death. Data on
amputation and stroke can be incomplete due to lack of
registration. Underreporting of stroke and amputation
diagnoses to the Danish National Registry of Patients would
lead to underestimation of risk.
634 L.V. Andersen et al.The main limitation of our study is lack of data on the use
of anti-thrombotic therapy. Temporal trends of stroke and
mortality indicate that there was no difference in risk of
stroke between the two periods, before and after 31
December 1996, but the risk of dying was higher in the early
period. We have previously reported a meta-analysis of
randomised controlled trials in patients with atrial fibrilla-
tion, which demonstrated that warfarin reduces risk of
systemic embolism by 50% when compared with anti-
platelet agents and by 71% when compared with placebo.27
Proper anti-thrombotic therapy with oral anticoagulants
that results in an international normalised ratio of 2 or
greater reduces the risk of stroke and death in patients with
atrial fibrillation.28,29 An apparent increased use of anti-
coagulation in the late period would probably also reduce
the risk of stroke in this period. However, it was not the
case. We believe that use of anti-thrombotic therapy did not
change significantly during the study period. A more plau-
sible explanation for decreasing mortality was improved
medical care and therapy of various diseases. In the general
population, expected life span has increased during the
study period.
In summary, upper-limb embolism requiring thrombo-
embolectomy is a rare but serious condition. After
thrombo-embolectomy, patients are at an increased risk of
upper-limb amputation, stroke and death.
Funding
The authors wish to thank Viborg County, The Medical
Association of Central Denmark Region, The Danish Medical
Association Research Fund/Højmosegaard-Legatet and The
Research Foundation at Silkeborg Hospital for supporting
this study.
The sponsors had no role in the study design, data
analysis, interpretation or writing of this manuscript.
Conflict of Interest
None of the authors has any conflicts of interest to declare.
References
1 Rutherford RB. Vascular surgery. 5th ed. Philadelphia, PA: W.B.
Saunders; 2000. pp. 813e835.
2 Hernandez-Richter T, Angele MK, Helmberger T, Jauch KW,
Lauterjung L, Schildberg FW. Acute ischemia of the upper
extremity: long-term results following thrombembolectomywith
the Fogarty catheter. Langenbecks Arch Surg 2001;386:261e6.
3 Dregelid EB, Stangeland LB, Eide GE, Trippestad A. Patient
survival and limb prognosis after arterial embolectomy. Eur J
Vasc Surg 1987;1:263e71.
4 Deguara J, Ali T, Modarai B, Burnand KG. Upper limb ischemia: 20
years experience from a single center. Vascular 2005;13:84e91.
5 Sorensen HT, Sabroe S, Olsen J. A framework for evaluation of
secondary data sources for epidemiological research. Int J
Epidemiol 1996;25:435e42.
6 The Danish Vascular Registry, http://www.karbase.dk/English/
english.htm; 2008.
7 The Danish National Registry of Patients, http://www.sst.dk/
Informatik_og_sundhedsdata/Registre_og_sundhedsstatistik/
Beskrivelse_af_registre/Landspatientregister.aspx?langZen;
2008.8 Andersen LV, Mortensen LS, Lindholt JS, Faergeman O,
Henneberg EW, Frost L. Completeness and positive predictive
value of registration of upper limb embolectomy in the Danish
National Vascular Registry. Clinical Epidemiology 2009;1:27e32.
9 Statistics Denmark, http://www.dst.dk/homeuk.aspx; 2008.
10 The Danish Civil Registry, http://www.cpr.dk/cpr/site.aspx?
pZ194&ArticleIDZ4326; 2008.
11 Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH.
The Danish National Hospital Register. A valuable source of data
for modern health sciences. Dan Med Bull. 1999;46:263e8.
12 Nelson CP, Lambert PC, Squire IB, Jones DR. Relative survival:
what can cardiovascular disease learn from cancer? Eur Heart J
2008;29:941e7.
13 La Marca G, La Barbera G, Rinaudo G, Ricevuto G, Martino A.
Acute upper limb ischemia of embolic origin: 682 cases. J Vasc
Endovasc Surge 2005;12:65e9.
14 Eyers P, Earnshaw JJ. Acute non-traumatic arm ischaemia. Br J
Surg 1998;85:1340e6.
15 Pentti J, Salenius JP, Kuukasjarvi P, Tarkka M. Outcome of
surgical treatment in acute upper limb ischaemia. Ann Chir
Gynaecol 1995;84:25e8.
16 Dryjski M, Swedenborg J. Acute ischemia of the extremities in
a metropolitan area during one year. J Cardiovasc Surg (Torino)
1984;25:518e22.
17 Katz SG, Kohl RD. Direct revascularization for the treatment of
forearm and hand ischemia. Am J Surg 1993;165:312e6.
18 Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B.
Placebo-controlled, randomised trial of warfarin and aspirin for
prevention of thromboembolic complications in chronic atrial
fibrillation. The Copenhagen AFASAK study. Lancet 1989;1:175e9.
19 Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA,
Joyner C. Canadian atrial fibrillation anticoagulation (CAFA)
Study. J Am Coll Cardiol 1991;18:349e55.
20 Stroke Prevention in Atrial Fibrillation Investigators. Stroke
prevention in atrial fibrillation study. Final results. Circulation
1991;84:527e39.
21 Zeiher AM, Schachinger V, Minners J. Long-term cigarette
smoking impairs endothelium-dependent coronary arterial
vasodilator function. Circulation 1995;92:1094e100.
22 Campbell WB, Ridler BM, Szymanska TH. Current management
of acute leg ischaemia: results of an audit by the Vascular
Surgical Society of Great Britain and Ireland. Br J Surg 1998;85:
1498e503.
23 Licht PB, Balezantis T, Wolff B, Baudier JF, Roder OC. Long-term
outcome following thrombembolectomy in the upper extremity.
Eur J Vasc Endovasc Surg 2004;28:508e12.
24 Friberg J, GislasonGH, Gadsbøll N, Rasmussen JN, Abildstrøm SZ,
et al. Temporal trends in theprescription of vitaminK antagonists
in patients with atrial fibrillation. J Intern Med 2006;259:173e8.
25 Krarup LH, Boysen G, Janjua H, Prescott E, Truelsen T. Validity
of stroke diagnoses in a national register of patients. Neuro-
epidemiology 2007;28:150e4.
26 Johnsen SP, Overvad K, Sorensen HT, Tjonneland A, Husted SE.
Predictive value of stroke and transient ischemic attack
discharge diagnoses in The Danish National Registry of Patients.
J Clin Epidemiol 2002;55:602e7.
27 Andersen LV, Vestergaard P, Deichgraeber P, Lindholt JS,
Mortensen LS, Frost L. Warfarin for the prevention of systemic
embolism in patients with non-valvular atrial fibrillation:
a meta-analysis. Heart 2008;94:1607e13.
28 Andersen KK, Olsen TS. Reduced poststroke mortality in
patients with stroke and atrial fibrillation treated with antico-
agulants: results from a Danish quality-control registry of
22,179 patients with ischemic stroke. Stroke 2007;38:259e63.
29 Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV,
et al. Effect of intensity of oral anticoagulation on stroke
severity and mortality in atrial fibrillation. N Engl J Med 2003;
349:1019e26.
